Glempa-M 5/500Mg Tab 14S

Glempa-M contains Empagliflozin 12.5mg + Metformin HCl 500mg, a combination oral antidiabetic medicine used to improve blood glucose control in adults with Type 2 diabetes. The manufacturer lists Glempa-M in several strengths, including 12.5/500mg, with a 14-tablet pack.

• Helps lower and control blood sugar levels.
• Empagliflozin reduces glucose reabsorption in the kidneys, increasing glucose removal through urine.
• Metformin reduces glucose production by the liver and improves insulin sensitivity.
• Used along with appropriate diet and exercise as prescribed.
• Possible side effects include increased urination, nausea, stomach discomfort, dehydration, and urinary or genital infections.
• Take only as directed by a healthcare professional.